NCT03148483

Brief Summary

The improvement of maternal and child health remains a key issue in global health. Production and improved accessibility of healthy and nutrient-rich milk-based products could potentially tackle health and nutrition inequalities in low-income countries. This study will assess the acceptability of a multi-component intervention, including provision of calcium/vitamin-D fortified milk and periodontal therapy (PT), for improving maternal periodontal health and metabolic and inflammatory profiles. The IMPROVE trial is a feasibility randomised controlled trial (RCT) with parallel qualitative process evaluation. The target population is low-income, pregnant, Brazilian women, with periodontitis, who have not seen a dentist in the last 6 months. A series of focus group discussions and interviews with the target population will be conducted to identify key barriers and enablers to adoption and implementation of the intervention in prenatal clinics in Rio de Janeiro/Brazil. Participants will be allocated to 4 groups: 1) early PT (during pregnancy) plus fortified milk; 2) early PT plus plain milk; 3) delayed PT (after delivery) plus fortified milk; 4) delayed PT plus plain milk. The final results will contribute to the understanding of the significance of calcium and vitamin D for short and long-term health and the occurrence of diseases, as well as to inform the current global debate on vitamin-D supplementation and fortification policy.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
70

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Apr 2017

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 27, 2016

Completed
6 months until next milestone

Study Start

First participant enrolled

April 24, 2017

Completed
17 days until next milestone

First Posted

Study publicly available on registry

May 11, 2017

Completed
1.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 30, 2018

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 30, 2018

Completed
Last Updated

August 3, 2021

Status Verified

July 1, 2021

Enrollment Period

1.1 years

First QC Date

October 27, 2016

Last Update Submit

July 27, 2021

Conditions

Keywords

Pregnancy outcomeFeasibilityMilk FortificationPeriodontitisPregnant womenPeriodontal Therapy

Outcome Measures

Primary Outcomes (3)

  • Feasibility (acceptability of study design, recruitment strategy, random allocation and data collection procedures)

    Feasibility will be evaluated using mixed-methods to explore intervention delivery, participants' acceptability, challenges and issues faced during the study, and recommended changes to the study design. Focus groups discussions will be held prior to trial recruitment to discuss issues regarding recruitment strategy, study design and data collection. In addition, group discussions will be held throughout the study (2nd and 3rd trimester) to assess potential barriers and facilitators to the intervention and data collection. At the end of each participant's involvement in the study, the participant will be asked to complete an anonymous, acceptability questionnaire to gain insights about participant's reactions to research participation and how acceptable the participant found study requirements and assessments were.

    From baseline till 6-8 weeks' postpartum

  • Recruitment rate

    This will be measured by the total number of participants recruited into the study. The investigators intend to recruit 120 participants. Recruitment rate will be calculated (number of participants per month)

    one year

  • Adherence

    number of drop-outs in each study arm. Analyses of drop-out rates (%) in four study arms. Self-reported quantity of milk consumed during the study. Number of follow-up visits. Proportion of participants who provide full data at baseline, throughout pregnancy and up to 6-8 weeks postpartum.

    From baseline till 6-8 weeks' postpartum

Secondary Outcomes (9)

  • Changes in % of sites with bleeding on probing

    baseline and 6-8 weeks' postpartum

  • Changes in maternal blood biomarkers to assess inflammation

    10 months on average

  • Changes in maternal serum levels of 25(OH)D

    10 months on average

  • Changes in maternal glucose levels

    10 months on

  • Changes in maternal insulin levels

    10 months on average

  • +4 more secondary outcomes

Study Arms (4)

Early PT plus Fortified Milk

EXPERIMENTAL

early periodontal therapy (during pregnancy) plus fortified milk

Other: Early PTDietary Supplement: Fortified Milk

Early PT plus Plain Milk

EXPERIMENTAL

early periodontal therapy (during pregnancy) plus plain milk

Other: Early PTDietary Supplement: Plain Milk

Delayed PT plus Fortified Milk

EXPERIMENTAL

delayed periodontal therapy (after delivery) plus fortified milk

Other: Delayed PTDietary Supplement: Fortified Milk

Delayed PT plus Plain Milk

PLACEBO COMPARATOR

delayed periodontal therapy (after delivery) plus plain milk

Other: Delayed PTDietary Supplement: Plain Milk

Interventions

Women will receive conventional non-surgical periodontal therapy (PT), consisting of prophylactic dental polishing to remove the sticky bacterial film that forms on the teeth over time, scaling and root planing, as necessary throughout pregnancy, up to delivery

Also known as: Early non-surgical periodontal therapy
Early PT plus Fortified MilkEarly PT plus Plain Milk

Women will receive conventional non-surgical PT delayed until after delivery.

Also known as: Delayed non-surgical periodontal therapy
Delayed PT plus Fortified MilkDelayed PT plus Plain Milk
Fortified MilkDIETARY_SUPPLEMENT

participants will be advised to take two servings of a powdered milk-based drink enriched with calcium and vitamin D daily during breakfast and afternoon snack or supper to avoid concomitant intake of the prenatal iron supplements routinely prescribed for consumption with hot main meals (e.g. lunch or dinner). Women will be advised to consume 20 g of commercially available semi-skimmed milk powder (provided by the study) and one sachet with 500 IU of vitamin D3 and 1,2 g of a calcium supplement from milk extract (300 mg of calcium) twice a day.

Delayed PT plus Fortified MilkEarly PT plus Fortified Milk
Plain MilkDIETARY_SUPPLEMENT

Women will be advised to consume 20 g of commercially available semi-skimmed milk powder (provided by the study) and one sachet with flour (placebo).

Also known as: non-fortified milk (placebo)
Delayed PT plus Plain MilkEarly PT plus Plain Milk

Eligibility Criteria

Age18 Years - 49 Years
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Aged ≥ 18 year;
  • Up to 16 weeks' gestation;
  • Having ≥ 20 teeth;
  • Diagnosis of periodontitis (≥ 1 tooth with at least one of periodontal sites with ≥ 4 mm of clinical attachment loss and bleeding on probing on the same site);
  • Not received regular dental treatment in the last 6 months (except from those who only visited the dentist for an emergency appointment e.g. tooth extraction);
  • Cognitively and physically able to complete an interview and oral examination; and
  • Willing to participate (including provision of blood samples)

You may not qualify if:

  • Diagnosis of HIV/AIDS, psychosis, diabetes before pregnancy, thyroid disease, or disorders causing vitamin D hypersensitivity (e.g. sarcoidosis and other lymphomatous disorders);
  • Diagnosis of lactose intolerance or milk allergy;
  • History of renal stones or family history of renal stone and hyperparathyroidism;
  • presence of extensive dental cavity and decay;
  • Use of antibiotics or any immune-suppressants or medication known to affect vitamin D/calcium metabolism; and
  • Consumption of ≥4 servings/day of dairy products or taking vitamin D supplements at \> 400 IU/day.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Centro Municipal de Saúde de Duque de Caxias & Policlínica Hospital Duque de Caxias

Rio de Janeiro, Brazil

Location

Related Publications (2)

  • Rodrigues Amorim Adegboye A, Cocate PG, Benaim C, da Veiga Soares Carvalho MC, Schlussel MM, de Castro MBT, Kac G, Heitmann BL. Recruitment of low-income pregnant women into a dietary and dental care intervention: lessons from a feasibility trial. Trials. 2020 Mar 5;21(1):244. doi: 10.1186/s13063-020-4142-5.

  • Cocate PG, Kac G, Heitmann BL, Nadanovsky P, da Veiga Soares Carvalho MC, Benaim C, Schlussel MM, de Castro MBT, Alves-Santos NH, Baptista AF, Holick MF, Mokhtar RR, Bomfim AR, Adegboye ARA. Calcium and vitamin D supplementation and/or periodontal therapy in the treatment of periodontitis among Brazilian pregnant women: protocol of a feasibility randomised controlled trial (the IMPROVE trial). Pilot Feasibility Stud. 2019 Mar 5;5:38. doi: 10.1186/s40814-019-0417-6. eCollection 2019.

MeSH Terms

Conditions

PeriodontitisInflammation

Condition Hierarchy (Ancestors)

Periodontal DiseasesMouth DiseasesStomatognathic DiseasesPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Masking Details
This is a multi-component intervention. The participants will be blinded for the milk fortification component of the intervention only. Participants will receive daily sachets with similar appearance either with vitamin D and calcium (intervention) or flour (control).
Purpose
TREATMENT
Intervention Model
FACTORIAL
Model Details: 2x2 factorial design
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Senior Lecturer, Principal Investigator

Study Record Dates

First Submitted

October 27, 2016

First Posted

May 11, 2017

Study Start

April 24, 2017

Primary Completion

May 30, 2018

Study Completion

May 30, 2018

Last Updated

August 3, 2021

Record last verified: 2021-07

Locations